Latent Tuberculosis Screening Among New Users of a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug: Gaps in Screening Overall and Among Janus Kinase Inhibitors
Eric T. Roberts,
Gabriela Schmajuk,
Jing Li
et al.
Abstract:ObjectiveWe combined claims and EHR data to provide contemporary and accurate estimates of latent TB screening among new users of a biologic or targeted synthetic DMARD and assess potential gaps in testing by drug type, patient characteristics, and practice.MethodsOur denominator population was patients in the RISE registry and Medicare using a b/tsDMARD in 2018 without a claim or prescription in the year prior. TB screening was assessed in both Medicare and RISE 1 and 3 years before the medication start date.… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.